Published in Mol Cell Biol on June 01, 1999
ETS2 and ERG promote megakaryopoiesis and synergize with alterations in GATA-1 to immortalize hematopoietic progenitor cells. Blood (2009) 2.45
Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol (2003) 1.42
Abnormal expression of FLI1 protein is an adverse prognostic factor in acute myeloid leukemia. Blood (2011) 1.34
Putative tumor suppressor miR-145 inhibits colon cancer cell growth by targeting oncogene Friend leukemia virus integration 1 gene. Cancer (2010) 1.34
The transcription factor Fli-1 modulates marginal zone and follicular B cell development in mice. J Immunol (2008) 1.16
A large gene network in immature erythroid cells is controlled by the myeloid and B cell transcriptional regulator PU.1. PLoS Genet (2011) 1.09
Negative and translation termination-dependent positive control of FLI-1 protein synthesis by conserved overlapping 5' upstream open reading frames in Fli-1 mRNA. Mol Cell Biol (2000) 1.08
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis. Crit Rev Biochem Mol Biol (2013) 1.08
Pathology of Ewing's sarcoma/PNET: Current opinion and emerging concepts. Indian J Orthop (2010) 1.02
PDEF is a negative regulator of colon cancer cell growth and migration. J Cell Biochem (2009) 1.01
Cell-nonautonomous function of the retinoblastoma tumour suppressor protein: new interpretations of old phenotypes. EMBO Rep (2002) 1.00
The splenic microenvironment is a source of proangiogenesis/inflammatory mediators accelerating the expansion of murine erythroleukemic cells. Blood (2005) 0.98
Direct regulation of BCL-2 by FLI-1 is involved in the survival of FLI-1-transformed erythroblasts. EMBO J (2002) 0.92
Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells. Mol Cell Biol (2009) 0.90
The ets transcription factor Fli-1 in development, cancer and disease. Oncogene (2014) 0.89
Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J (2012) 0.88
Visualizing dynamic E2F-mediated repression in vivo. Mol Cell Biol (2006) 0.86
Activation of the Jun N-terminal kinase pathway by friend spleen focus-forming virus and its role in the growth and survival of friend virus-induced erythroleukemia cells. J Virol (2005) 0.86
Enhanced natural-killer cell and erythropoietic activities in VEGF-A-overexpressing mice delay F-MuLV-induced erythroleukemia. Blood (2006) 0.86
FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia (2014) 0.84
p45(NFE2) is a negative regulator of erythroid proliferation which contributes to the progression of Friend virus-induced erythroleukemias. Mol Cell Biol (2001) 0.84
Downregulation of Friend leukemia virus integration 1 as a feedback mechanism that restrains lipopolysaccharide induction of matrix metalloproteases and interleukin-10 in human macrophages. J Interferon Cytokine Res (2010) 0.82
Transdifferentiation of Human Hair Follicle Mesenchymal Stem Cells into Red Blood Cells by OCT4. Stem Cells Int (2015) 0.77
miR-145 promotes osteosarcoma growth by reducing expression of the transcription factor friend leukemia virus integration 1. Oncotarget (2016) 0.75
FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain. J Immunol (2015) 0.75
Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer. BMC Cancer (2014) 0.75
Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway. Oncotarget (2017) 0.75
Fli-1 overexpression in erythroleukemic cells promotes erythroid de-differentiation while Spi-1/PU.1 exerts the opposite effect. Int J Oncol (2017) 0.75
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem (1973) 24.38
Cancer cell cycles. Science (1996) 21.29
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res (1991) 13.54
Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide. Proc Natl Acad Sci U S A (1971) 11.41
Effects of an Rb mutation in the mouse. Nature (1992) 11.06
Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature (1991) 10.30
Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature (1989) 9.08
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature (1992) 8.16
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature (1992) 7.68
Requirement for a functional Rb-1 gene in murine development. Nature (1992) 6.87
The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature (1988) 6.35
A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell (1991) 6.14
Mapping protein-DNA interactions in vivo with formaldehyde: evidence that histone H4 is retained on a highly transcribed gene. Cell (1988) 5.08
Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. Science (1991) 4.98
Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature (1995) 4.97
Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell (1995) 4.73
Mapping Polycomb-repressed domains in the bithorax complex using in vivo formaldehyde cross-linked chromatin. Cell (1993) 4.01
The transcriptional control of hematopoiesis. Blood (1996) 3.72
Identification of Ets- and notch-related subunits in GA binding protein. Science (1991) 3.69
Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature (1988) 3.59
Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev (1991) 3.54
Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science (1990) 3.46
Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. Genes Dev (1989) 3.29
Expression of c-myc changes during differentiation of mouse erythroleukaemia cells. Nature (1984) 3.09
Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci U S A (1993) 3.07
Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature (1985) 2.98
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A (1993) 2.90
G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell (1991) 2.87
Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol Cell Biol (1992) 2.78
Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol (1988) 2.70
Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J (1994) 2.57
Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature (1986) 2.57
Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature (1986) 2.54
Molecular biology of Friend viral erythroleukemia. Curr Top Microbiol Immunol (1989) 2.52
Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J (1994) 2.44
Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc Natl Acad Sci U S A (1991) 2.26
Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Dev (1996) 2.18
Receptor tyrosine kinases: genetic evidence for their role in Drosophila and mouse development. Trends Genet (1990) 2.01
Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemic cell lines induced by Friend leukemia virus. Oncogene (1988) 1.96
Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. Proc Natl Acad Sci U S A (1994) 1.84
Structure, function, and activation of the erythropoietin receptor. Blood (1993) 1.77
Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proc Natl Acad Sci U S A (1988) 1.65
Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol (1991) 1.65
Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles. Mol Cell Biol (1990) 1.58
The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities. J Biol Chem (1994) 1.56
Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. Proc Natl Acad Sci U S A (1994) 1.52
Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci U S A (1996) 1.39
Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol Cell Biol (1996) 1.38
Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood (1995) 1.34
The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene (1997) 1.34
Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein. Oncogene (1993) 1.32
Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. J Virol (1987) 1.32
The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J Biol Chem (1998) 1.31
Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol (1994) 1.29
Isolation and induction of erythroleukemic cell lines with properties of erythroid progenitor burst-forming cell (BFU-E) and erythroid precursor cell (CFU-E). Proc Natl Acad Sci U S A (1983) 1.27
The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene (1993) 1.27
c-myc mRNA levels in the cell cycle change in mouse erythroleukemia cells following inducer treatment. Proc Natl Acad Sci U S A (1985) 1.24
Functional interaction of erythropoietin and stem cell factor receptors is essential for erythroid colony formation. Proc Natl Acad Sci U S A (1997) 1.19
Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ (1994) 1.18
Friend leukaemia virus-transformed cells, unlike normal stem cells, form spleen colonies in Sl/sld mice. Nature (1980) 1.16
Erythropoietin receptor signals both proliferation and erythroid-specific differentiation. Proc Natl Acad Sci U S A (1993) 1.10
Integration of Friend murine leukemia virus into both alleles of the p53 oncogene in an erythroleukemic cell line. J Virol (1988) 1.10
Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control. Cell Growth Differ (1995) 1.09
Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb mRNA. Science (1990) 1.08
In vitro-derived leukemic erythroid cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin. Proc Natl Acad Sci U S A (1988) 1.05
Molecular cloning and characterization of the mouse RB1 promoter. Oncogene (1993) 1.00
Retinoblastoma binding factor 1 site in the core promoter region of the human RB gene is activated by hGABP/E4TF1. Cancer Res (1997) 0.98
Distinct signaling from stem cell factor and erythropoietin in HCD57 cells. J Biol Chem (1997) 0.98
Retinoblastoma gene deficiency has mitogenic but not tumorigenic effects on erythropoiesis. Cancer Res (1997) 0.98
The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family. Oncogene (1994) 0.97
Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene (1993) 0.96
Effects of recombinant human stem cell factor (SCF) on the growth of human progenitor cells in vitro. J Cell Physiol (1991) 0.91
Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation. Blood (1997) 0.88
Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Oncogene (1996) 0.83
p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias. Cell Growth Differ (1996) 0.81
Flexural rigidity of microtubules and actin filaments measured from thermal fluctuations in shape. J Cell Biol (1993) 9.84
Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet (1995) 4.28
Emerging infectious diseases and amphibian population declines. Emerg Infect Dis (2000) 4.27
Mechanical relaxation of the hair bundle mediates adaptation in mechanoelectrical transduction by the bullfrog's saccular hair cell. Proc Natl Acad Sci U S A (1987) 4.02
Diagnostic assays and sampling protocols for the detection of Batrachochytrium dendrobatidis. Dis Aquat Organ (2007) 3.78
Processivity of the motor protein kinesin requires two heads. J Cell Biol (1998) 3.36
The force exerted by a single kinesin molecule against a viscous load. Biophys J (1994) 3.33
Kinesin follows the microtubule's protofilament axis. J Cell Biol (1993) 3.32
Kinesin's tail domain is an inhibitory regulator of the motor domain. Nat Cell Biol (1999) 3.26
Rigidity of microtubules is increased by stabilizing agents. J Cell Biol (1995) 2.93
The A1 and A1B proteins of heterogeneous nuclear ribonucleoparticles modulate 5' splice site selection in vivo. Proc Natl Acad Sci U S A (1994) 2.92
The force generated by a single kinesin molecule against an elastic load. Proc Natl Acad Sci U S A (1995) 2.85
Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother (1985) 2.66
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut (2009) 2.62
Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet (1998) 2.53
Insertion, excision, and inversion of Tn5. Cold Spring Harb Symp Quant Biol (1981) 2.37
Kinesin takes one 8-nm step for each ATP that it hydrolyzes. J Biol Chem (1999) 2.37
Epidemiology of signs and symptoms in temporomandibular disorders: clinical signs in cases and controls. J Am Dent Assoc (1990) 2.32
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet (2000) 2.31
Kinesin's processivity results from mechanical and chemical coordination between the ATP hydrolysis cycles of the two motor domains. Proc Natl Acad Sci U S A (1999) 2.27
Can bacterial interference prevent infection? Trends Microbiol (2001) 2.26
PRIMARY CARCINOMA OF THE DUODENUM. Ann Surg (1942) 2.19
In vivo methylation by Escherichia coli K-12 mec+ deoxyribonucleic acid-cytosine methylase protects against in vitro cleavage by the RII restriction endonuclease (R. Eco RII). J Bacteriol (1976) 2.15
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer (1998) 2.09
Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet (1986) 2.07
Stiffness of sensory hair bundles in the sacculus of the frog. Hear Res (1986) 1.98
The effects of race and occupation on hypertension mortality. Milbank Mem Fund Q (1970) 1.96
Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol (2001) 1.94
Comparative study of DNA methylation in three unicellular eucaryotes. J Bacteriol (1978) 1.93
Kinesin swivels to permit microtubule movement in any direction. Proc Natl Acad Sci U S A (1993) 1.91
Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence. Arch Microbiol (1989) 1.85
Using mammography for cancer control: an unrealized potential. CA Cancer J Clin (1987) 1.85
Retroviral integration within the Fli-2 locus results in inactivation of the erythroid transcription factor NF-E2 in Friend erythroleukemias: evidence that NF-E2 is essential for globin expression. Proc Natl Acad Sci U S A (1994) 1.84
Visiting a forest, but not a city, increases human natural killer activity and expression of anti-cancer proteins. Int J Immunopathol Pharmacol (2008) 1.76
Directional loading of the kinesin motor molecule as it buckles a microtubule. Biophys J (1996) 1.73
Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A (1997) 1.68
Chromoblastomycosis due to a New Species of Fungus: (First Canadian Case). Can Med Assoc J (1945) 1.66
Amelioration of alkali soil using flue gas desulfurization byproducts: productivity and environmental quality. Environ Pollut (2007) 1.63
A forest bathing trip increases human natural killer activity and expression of anti-cancer proteins in female subjects. J Biol Regul Homeost Agents (2008) 1.61
Hair cells: transduction, tuning, and transmission in the inner ear. Annu Rev Cell Biol (1988) 1.59
Immunoglobulin VH gene structure and diversity in Heterodontus, a phylogenetically primitive shark. Proc Natl Acad Sci U S A (1985) 1.54
Conformational changes during kinesin motility. Curr Opin Cell Biol (2001) 1.53
Early carotid endarterectomy after intravenous thrombolysis for acute ischaemic stroke. Eur J Vasc Endovasc Surg (2009) 1.52
Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. Eur J Biochem (1995) 1.50
A mammalian dual specificity protein kinase, Nek1, is related to the NIMA cell cycle regulator and highly expressed in meiotic germ cells. EMBO J (1992) 1.49
Ectro-amelia syndrome associated with an interstitial deletion of 7q. Am J Med Genet (1990) 1.46
[Chytridiomycosis in amphibians--first report in Europe]. Berl Munch Tierarztl Wochenschr (2000) 1.45
Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer (2003) 1.44
The role of Fli-1 in normal cell function and malignant transformation. Oncogene (2000) 1.43
Multiple cDNAs encoding the esk kinase predict transmembrane and intracellular enzyme isoforms. Mol Cell Biol (1992) 1.42
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis. Clin Infect Dis (1996) 1.40
The efficacy of oral steroids in the treatment of persistent otitis media with effusion. Arch Otolaryngol Head Neck Surg (1990) 1.39
High-precision tracking of sperm swimming fine structure provides strong test of resistive force theory. J Exp Biol (2010) 1.37
The ultrasound diagnosis and clinical significance of varicocele. Ultrasound Obstet Gynecol (1995) 1.36
Complete nucleotide sequences of three VH genes in Caiman, a phylogenetically ancient reptile: evolutionary diversification in coding segments and variation in the structure and organization of recombination elements. Proc Natl Acad Sci U S A (1985) 1.34
Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. Am J Med (1975) 1.34
Synaptic limitations to contrast coding in the retina of the blowfly Calliphora. Proc R Soc Lond B Biol Sci (1987) 1.34
The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene (1997) 1.34
Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes. J Virol (1987) 1.32
Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus. Virology (2007) 1.31
Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease. Am J Med (1982) 1.30
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members. Oncogene (1993) 1.27
Normal range values for thromboelastography in healthy adult volunteers. Braz J Med Biol Res (2009) 1.24
Immunity to lantibiotics. Antonie Van Leeuwenhoek (1996) 1.24
Incidence of non-fatal workplace assault injuries determined from employer's reports in California. J Occup Environ Med (1997) 1.22
Age-related morphine kinetics. Clin Pharmacol Ther (1983) 1.21
Renal function in gout. 3. Estimation of tubular secretion and reabsorption of uric acid by use of pyrazinamide (pyrazinoic acid). Am J Med (1969) 1.20
Detection of arboviral RNA directly from mosquito homogenates by reverse-transcription-polymerase chain reaction. J Virol Methods (2001) 1.19
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse. Leukemia (2005) 1.19
Recurrent vulvovaginal candidiasis. A gynaecological enigma. Aust Fam Physician (1989) 1.19
Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia. Leukemia (2011) 1.18
The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy. J Trop Pediatr (2005) 1.18
Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ (1994) 1.18
Cryo-archiving of Batrachochytrium dendrobatidis and other chytridiomycetes. Dis Aquat Organ (2003) 1.17
Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations. Oncogene (2010) 1.16
A multicenter investigation with D-FISH BCR/ABL1 probes. Cancer Genet Cytogenet (2000) 1.16
Construction of an expression system for engineering of the lantibiotic Pep5. Appl Environ Microbiol (1994) 1.16
cdc2 phosphorylation of threonine 124 activates the origin-unwinding functions of simian virus 40 T antigen. J Virol (1993) 1.15
A balancing act: the tension between case-finding and primary prevention strategies in New York State's voluntary HIV counseling and testing program in women's health care settings. Am J Prev Med (1997) 1.14
Localization of type 5 17beta-hydroxysteroid dehydrogenase, 3beta-hydroxysteroid dehydrogenase, and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology (1999) 1.14
Needle sharing in the Haight: some social and psychological functions. J Health Soc Behav (1970) 1.13
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Time for an ecosystem approach to public health? Lessons from two infectious disease outbreaks in Canada. Glob Public Health (2009) 1.13
A multicenter investigation with interphase fluorescence in situ hybridization using X- and Y-chromosome probes. Am J Med Genet (1998) 1.11
Characterization of the mammalian septin H5: distinct patterns of cytoskeletal and membrane association from other septin proteins. Cell Motil Cytoskeleton (1999) 1.10
Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course. J Acquir Immune Defic Syndr (1994) 1.10
Drinking water quality management: a holistic approach. Water Sci Technol (2003) 1.10
Psychopathology, mother-child interaction, and infant development: substance-abusing mothers and their offspring. Dev Psychopathol (1999) 1.10
TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Oncogene (1996) 1.09
Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations. Int J Cancer (1999) 1.09
'Avoidable mortality' from cervical cancer: exploring the concept. Soc Sci Med (1987) 1.08
Hospital variations in metastatic breast cancer. Med Care (1980) 1.07
An outbreak of mucormycosis in slender tree frogs (Litoria adelensis) and white-lipped tree frogs (Litoria infrafrenata) Aust Vet J (1998) 1.07
A possible role for BDNF, NT-4 and TrkB in the spinal cord and muscle of rat subjected to mechanical overload, bupivacaine injection and axotomy. Brain Res (2001) 1.07
Toxicity of irinotecan-eluting beads in the treatment of hepatic malignancies: results of a multi-institutional registry. Cardiovasc Intervent Radiol (2010) 1.07
A rapid, quantitative, and highly specific assay for carbohydrate-binding proteins. Anal Biochem (1977) 1.06
Absence of HIV-1 DNA in high-risk seronegative individuals using high-input polymerase chain reaction. AIDS (1991) 1.06
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans. Mol Psychiatry (2011) 1.06